As Amicus Therapeutics (FOLD) Stock Rose, Longwood Capital Partners Has Decreased Position by $1.50 Million; Home Depot (HD) Holder United Asset Strategies Has Trimmed Its Stake by $5.24 Million

April 17, 2018 - By Nellie Frank

The Home Depot, Inc. (NYSE:HD) Logo

United Asset Strategies Inc decreased its stake in Home Depot Inc (HD) by 81.1% based on its latest 2017Q4 regulatory filing with the SEC. United Asset Strategies Inc sold 27,722 shares as the company’s stock declined 7.15% with the market. The institutional investor held 6,461 shares of the consumer services company at the end of 2017Q4, valued at $1.22 million, down from 34,183 at the end of the previous reported quarter. United Asset Strategies Inc who had been investing in Home Depot Inc for a number of months, seems to be less bullish one the $202.21B market cap company. The stock increased 0.57% or $0.99 during the last trading session, reaching $175.42. About 802,289 shares traded. The Home Depot, Inc. (NYSE:HD) has risen 18.94% since April 17, 2017 and is uptrending. It has outperformed by 7.39% the S&P500.

Longwood Capital Partners Llc decreased its stake in Amicus Therapeutics Inc (FOLD) by 70.93% based on its latest 2017Q4 regulatory filing with the SEC. Longwood Capital Partners Llc sold 107,100 shares as the company’s stock rose 0.85% while stock markets declined. The institutional investor held 43,900 shares of the health care company at the end of 2017Q4, valued at $632,000, down from 151,000 at the end of the previous reported quarter. Longwood Capital Partners Llc who had been investing in Amicus Therapeutics Inc for a number of months, seems to be less bullish one the $2.75 billion market cap company. The stock increased 1.77% or $0.255 during the last trading session, reaching $14.645. About 326,847 shares traded. Amicus Therapeutics, Inc. (NASDAQ:FOLD) has risen 90.40% since April 17, 2017 and is uptrending. It has outperformed by 78.85% the S&P500.

United Asset Strategies Inc, which manages about $731.00 million and $373.01M US Long portfolio, upped its stake in Ishares Tr (FXI) by 9,394 shares to 29,716 shares, valued at $1.37M in 2017Q4, according to the filing. It also increased its holding in Boeing Co (NYSE:BA) by 1,607 shares in the quarter, for a total of 3,699 shares, and has risen its stake in Apple Inc (NASDAQ:AAPL).

Investors sentiment decreased to 0.93 in 2017 Q4. Its down 0.21, from 1.14 in 2017Q3. It turned negative, as 51 investors sold HD shares while 662 reduced holdings. 164 funds opened positions while 501 raised stakes. 788.59 million shares or 0.96% less from 796.24 million shares in 2017Q3 were reported. Brick Kyle owns 2,400 shares. 843,674 were reported by Aperio Group Lc. Roanoke Asset New York reported 4.61% in The Home Depot, Inc. (NYSE:HD). Centre Asset Mgmt Llc stated it has 40,757 shares. 26,494 were accumulated by Marshall Sullivan Wa. Arcadia Investment Corp Mi has invested 1.12% in The Home Depot, Inc. (NYSE:HD). Verity And Verity Lc has 0.07% invested in The Home Depot, Inc. (NYSE:HD). Brighton Jones Ltd Limited Liability Company holds 0.32% of its portfolio in The Home Depot, Inc. (NYSE:HD) for 13,731 shares. Cohen Lawrence B owns 1,813 shares or 0.22% of their US portfolio. Wedgewood Pa reported 0.83% of its portfolio in The Home Depot, Inc. (NYSE:HD). California-based Hollencrest Capital has invested 0.08% in The Home Depot, Inc. (NYSE:HD). Arete Wealth Advisors Ltd Liability Com owns 2,063 shares or 0.13% of their US portfolio. Stearns Fincl Services Group accumulated 9,920 shares or 0.45% of the stock. Brookstone Capital Management has invested 0.17% in The Home Depot, Inc. (NYSE:HD). Art Advsr Limited Liability Company holds 0.26% of its portfolio in The Home Depot, Inc. (NYSE:HD) for 31,000 shares.

Since December 7, 2017, it had 2 buys, and 5 sales for $36.57 million activity. On Friday, December 8 the insider Carey Matt sold $7.58M. Shares for $7.02M were sold by Campbell Ann Marie on Thursday, February 22. 16,827 The Home Depot, Inc. (NYSE:HD) shares with value of $3.00M were bought by BRENNEMAN GREGORY D. On Thursday, December 7 Roseborough Teresa Wynn sold $1.97M worth of The Home Depot, Inc. (NYSE:HD) or 10,916 shares. 113,687 shares valued at $20.89M were sold by Menear Craig A on Wednesday, February 21. The insider Decker Edward P. sold 17,660 shares worth $3.31 million.

Among 34 analysts covering The Home Depot Inc. (NYSE:HD), 24 have Buy rating, 0 Sell and 10 Hold. Therefore 71% are positive. The Home Depot Inc. had 116 analyst reports since August 19, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, December 15 by BMO Capital Markets. Credit Suisse maintained The Home Depot, Inc. (NYSE:HD) rating on Monday, December 7. Credit Suisse has “Outperform” rating and $135 target. The stock of The Home Depot, Inc. (NYSE:HD) earned “Buy” rating by Jefferies on Friday, May 13. The rating was maintained by Robert W. Baird with “Buy” on Thursday, November 30. The rating was upgraded by Morgan Stanley to “Overweight” on Thursday, February 23. The stock of The Home Depot, Inc. (NYSE:HD) earned “Buy” rating by UBS on Wednesday, November 15. The rating was maintained by Jefferies on Wednesday, September 13 with “Buy”. The rating was upgraded by Raymond James on Wednesday, August 16 to “Outperform”. UBS maintained it with “Buy” rating and $212.0 target in Friday, January 26 report. Credit Suisse maintained The Home Depot, Inc. (NYSE:HD) rating on Wednesday, November 18. Credit Suisse has “Outperform” rating and $135 target.

Analysts await The Home Depot, Inc. (NYSE:HD) to report earnings on May, 15. They expect $2.08 earnings per share, up 24.55% or $0.41 from last year’s $1.67 per share. HD’s profit will be $2.40B for 21.08 P/E if the $2.08 EPS becomes a reality. After $1.69 actual earnings per share reported by The Home Depot, Inc. for the previous quarter, Wall Street now forecasts 23.08% EPS growth.

Investors sentiment decreased to 1.21 in Q4 2017. Its down 1.12, from 2.33 in 2017Q3. It is negative, as 25 investors sold FOLD shares while 48 reduced holdings. 25 funds opened positions while 63 raised stakes. 197.59 million shares or 2.54% more from 192.70 million shares in 2017Q3 were reported. Jpmorgan Chase & Communications owns 990,360 shares. California-based Schwab Charles Invest Mngmt Inc has invested 0.01% in Amicus Therapeutics, Inc. (NASDAQ:FOLD). Price T Rowe Associates Md owns 9.06M shares. Moreover, Adams Diversified Equity Fund has 0.03% invested in Amicus Therapeutics, Inc. (NASDAQ:FOLD). Natl Bank Of Ny Mellon Corp holds 0% or 879,536 shares. Birchview Cap Limited Partnership stated it has 0.08% in Amicus Therapeutics, Inc. (NASDAQ:FOLD). D E Shaw & owns 2.46 million shares. Tower Research Capital (Trc) stated it has 0% in Amicus Therapeutics, Inc. (NASDAQ:FOLD). Mutual Of America Cap Ltd Limited Liability Company invested 0.05% in Amicus Therapeutics, Inc. (NASDAQ:FOLD). Proshare Ltd Llc holds 114,365 shares or 0.01% of its portfolio. 152,000 were reported by Quantitative Invest Mngmt Ltd Limited Liability Company. 652,017 were reported by Bank & Trust Of America Corporation De. California State Teachers Retirement Systems has invested 0.01% of its portfolio in Amicus Therapeutics, Inc. (NASDAQ:FOLD). 1,180 were reported by Mufg Americas Holdg. Teachers Retirement Systems Of The State Of Kentucky accumulated 48,293 shares.

Among 9 analysts covering Amicus Therapeutics (NASDAQ:FOLD), 8 have Buy rating, 0 Sell and 1 Hold. Therefore 89% are positive. Amicus Therapeutics had 22 analyst reports since August 18, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Tuesday, January 24 by Robert W. Baird. The stock of Amicus Therapeutics, Inc. (NASDAQ:FOLD) earned “Outperform” rating by Leerink Swann on Thursday, February 8. As per Monday, August 31, the company rating was maintained by Leerink Swann. The rating was maintained by Robert W. Baird with “Outperform” on Wednesday, July 12. Chardan Capital Markets upgraded Amicus Therapeutics, Inc. (NASDAQ:FOLD) rating on Monday, October 5. Chardan Capital Markets has “Buy” rating and $8 target. Robert W. Baird initiated Amicus Therapeutics, Inc. (NASDAQ:FOLD) on Thursday, April 14 with “Neutral” rating. The stock of Amicus Therapeutics, Inc. (NASDAQ:FOLD) earned “Neutral” rating by Goldman Sachs on Wednesday, March 30. As per Sunday, August 13, the company rating was maintained by Cowen & Co. The stock has “Buy” rating by Robert W. Baird on Wednesday, February 7. The company was downgraded on Tuesday, August 18 by Zacks.

Since October 17, 2017, it had 3 insider buys, and 14 selling transactions for $4.83 million activity. On Tuesday, January 2 the insider Andrews Kurt J. sold $147,191. On Monday, March 12 Barth Jay sold $75,253 worth of Amicus Therapeutics, Inc. (NASDAQ:FOLD) or 5,000 shares. The insider RAAB MICHAEL sold $140,490. On Tuesday, January 2 the insider Baird William D III sold $147,181. HAYDEN DONALD J JR sold $300,002 worth of Amicus Therapeutics, Inc. (NASDAQ:FOLD) on Tuesday, January 2. 71,735 Amicus Therapeutics, Inc. (NASDAQ:FOLD) shares with value of $1.06 million were sold by Crowley John F.

Analysts await Amicus Therapeutics, Inc. (NASDAQ:FOLD) to report earnings on May, 8. They expect $-0.36 earnings per share, up 7.69% or $0.03 from last year’s $-0.39 per share. After $-0.41 actual earnings per share reported by Amicus Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -12.20% EPS growth.

The Home Depot, Inc. (NYSE:HD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Nellie Frank

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: